PeptiDream, Inc. engages in the biopharmaceutical business that includes research and development of non-standard peptide therapeutics. The company is headquartered in Kawasaki-Shi, Kanagawa-Ken. The company went IPO on 2013-06-11. The firm operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The firm is involved in the business centered on drug development based on special peptides. The firm's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Dr. Patrick Reid est le President de PeptiDream Inc, il a rejoint l'entreprise depuis 2008.
Quelle est la performance du prix de l'action Peptidream, Inc. ?
Le prix actuel de Peptidream, Inc. est de $7.75, il a 下降 de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de PeptiDream Inc ?
PeptiDream Inc appartient à l'industrie Biotechnology et le secteur est Health Care
Quel est la capitalisation boursière de PeptiDream Inc ?
La capitalisation boursière actuelle de PeptiDream Inc est de $1.0B
Est-ce que PeptiDream Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 10 analystes ont établi des notations d'analystes pour PeptiDream Inc, y compris 3 achat fort, 8 achat, 1 maintien, 0 vente et 3 vente forte